Ralliant (NYSE:RAL) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Ralliant (NYSE:RAL) from a buy rating to a strong-buy rating in a research report released on Saturday morning.

Other equities research analysts have also issued reports about the company. Evercore initiated coverage on Ralliant in a research note on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price objective on the stock. BMO Capital Markets started coverage on Ralliant in a research note on Monday, July 20th. They issued a “market perform” rating and a $78.00 price target on the stock. Barclays upped their price target on Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research report on Wednesday, May 13th. Zacks Research raised Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Finally, Morgan Stanley boosted their target price on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a research note on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Price Performance

Shares of Ralliant stock opened at $62.84 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The firm’s 50-day simple moving average is $68.83 and its 200-day simple moving average is $56.00. Ralliant has a twelve month low of $37.27 and a twelve month high of $75.41. The firm has a market cap of $6.95 billion, a P/E ratio of -5.79, a price-to-earnings-growth ratio of 2.36 and a beta of 1.61.

Ralliant (NYSE:RAL) last posted its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The business had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, research analysts expect that Ralliant will post 2.87 EPS for the current fiscal year.

Ralliant Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio is currently -1.84%.

Insider Activity

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the completion of the sale, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. This trade represents a 4.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. This represents a 16.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new position in Ralliant in the 2nd quarter valued at $1,039,481,000. Dodge & Cox raised its position in shares of Ralliant by 13.3% during the fourth quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after acquiring an additional 1,434,376 shares during the last quarter. California State Teachers Retirement System raised its position in shares of Ralliant by 7,051.8% during the second quarter. California State Teachers Retirement System now owns 9,356,090 shares of the company’s stock worth $688,889,000 after acquiring an additional 9,225,268 shares during the last quarter. Viking Global Investors LP acquired a new position in shares of Ralliant during the second quarter valued at $257,200,000. Finally, Millennium Management LLC lifted its stake in shares of Ralliant by 172.4% during the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock valued at $253,175,000 after acquiring an additional 3,147,660 shares during the period.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.